Table of Contents Author Guidelines Submit a Manuscript
The Scientific World Journal
Volume 2014, Article ID 957107, 9 pages
http://dx.doi.org/10.1155/2014/957107
Research Article

Cheminformatics Models for Inhibitors of Schistosoma mansoni Thioredoxin Glutathione Reductase

1GN Ramachandran Knowledge Center for Genome Informatics, CSIR Institute of Genomics and Integrative Biology, Mall Road, Delhi 110007, India
2CSIR Open Source Drug Discovery Unit, Anusandhan Bhawan, 2 Rafi Marg, Delhi 110001, India

Received 8 July 2014; Revised 13 September 2014; Accepted 1 October 2014; Published 25 November 2014

Academic Editor: Yudong Cai

Copyright © 2014 Sonam Gaba et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. Steinmann, J. Keiser, R. Bos, M. Tanner, and J. Utzinger, “Schistosomiasis and water resources development: systematic review, meta-analysis, and estimates of people at risk,” Lancet Infectious Diseases, vol. 6, no. 7, pp. 411–425, 2006. View at Publisher · View at Google Scholar · View at Scopus
  2. D. Engels, L. Chitsulo, A. Montresor, and L. Savioli, “The global epidemiological situation of schistosomiasis and new approaches to control and research,” Acta Tropica, vol. 82, no. 2, pp. 139–146, 2002. View at Publisher · View at Google Scholar · View at Scopus
  3. WHO Expert Committee, “Preventeion and control of schistosomiasis and soil-transmitted helminthiasis,” Tech. Rep. 912, World Health Organization, 2002. View at Google Scholar
  4. M. J. Doenhoff, D. Cioli, and J. Utzinger, “Praziquantel: mechanisms of action, resistance and new derivatives for schistosomiasis,” Current Opinion in Infectious Diseases, vol. 21, no. 6, pp. 659–667, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. J. Utzinger, J. Keiser, X. Shuhua, M. Tanner, and B. H. Singer, “Combination chemotherapy of schistosomiasis in laboratory studies and clinical trials,” Antimicrobial Agents and Chemotherapy, vol. 47, no. 5, pp. 1487–1495, 2003. View at Publisher · View at Google Scholar · View at Scopus
  6. M. O. Oniya, M. A. Ishola, and O. D. Jayeoba, “Schistosomiasis in ipogun: update assessment endemicity and efficacy of praziquantel in chemotherapy,” International Journal of Tropical Disease and Health, vol. 3, no. 1, pp. 37–44, 2013. View at Google Scholar
  7. P. G. Fallon and M. J. Doenhoff, “Drug-resistant schistosomiasis: resistance to praziquantel and oxamniquine induced in Schistosoma mansoni in mice is drug specific,” The American Journal of Tropical Medicine and Hygiene, vol. 51, no. 1, pp. 83–88, 1994. View at Google Scholar · View at Scopus
  8. F. Angelucci, A. E. Miele, G. Boumis, D. Dimastrogiovanni, M. Brunori, and A. Bellelli, “Glutathione reductase and thioredoxin reductase at the crossroad: the structure of Schistosoma mansoni thioredoxin glutathione reductase,” Proteins: Structure, Function and Genetics, vol. 72, no. 3, pp. 936–945, 2008. View at Publisher · View at Google Scholar · View at Scopus
  9. F. Angelucci, D. Dimastrogiovanni, G. Boumis et al., “Mapping the catalytic cycle of Schistosoma mansoni thioredoxin glutathione reductase by X-ray crystallography,” The Journal of Biological Chemistry, vol. 285, no. 42, pp. 32557–32567, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. A. N. Kuntz, E. Davioud-Charvet, A. Sayed et al., “Thioredoxin glutathione reductase from Schistosoma mansoni: an essential parasite enzyme and a key drug target,” PLoS Medicine, vol. 4, no. 6, article e206, 2007. View at Google Scholar
  11. F. Angelucci, A. A. Sayed, D. L. Williams et al., “Inhibition of schistosoma mansoni thioredoxin-glutathione reductase by Auranofin. Structural and kinetic aspects,” Journal of Biological Chemistry, vol. 284, no. 42, pp. 28977–28985, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. B. Cox, J. C. Denyer, A. Binnie et al., “Application of high-throughput screening techniques to drug discovery,” Progress in Medicinal Chemistry, vol. 37, pp. 83–133, 2000. View at Publisher · View at Google Scholar · View at Scopus
  13. P. M. Selzer, S. Brutsche, P. Wiesner, P. Schmid, and H. Müllner, “Target-based drug discovery for the development of novel antiinfectives,” International Journal of Medical Microbiology, vol. 290, no. 2, pp. 191–201, 2000. View at Publisher · View at Google Scholar · View at Scopus
  14. J. H. F. Remme, E. Blas, L. Chitsulo et al., “Strategic emphases for tropical diseases research: a TDR perspective,” Trends in Microbiology, vol. 10, no. 10, pp. 435–440, 2002. View at Publisher · View at Google Scholar · View at Scopus
  15. S. Nwaka and A. Hudson, “Innovative lead discovery strategies for tropical diseases,” Nature Reviews Drug Discovery, vol. 5, no. 11, pp. 941–955, 2006. View at Publisher · View at Google Scholar · View at Scopus
  16. V. Periwal, S. Kishtapuram, and V. Scaria, “Computational models for in-vitro anti-tubercular activity of molecules based on high-throughput chemical biology screening datasets,” BMC Pharmacology, vol. 12, article 1, 2012. View at Publisher · View at Google Scholar · View at Scopus
  17. V. Periwal, J. K. Rajappan, A. U. C. Jaleel, and V. Scaria, “Predictive models for anti-tubercular molecules using machine learning on high-throughput biological screening datasets,” BMC Research Notes, vol. 4, article 504, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. S. Jamal, V. Periwal, and V. Scaria, “Predictive modeling of anti-malarial molecules inhibiting apicoplast formation,” BMC Bioinformatics, vol. 14, article 55, 2013. View at Publisher · View at Google Scholar · View at Scopus
  19. S. Jamal, V. Periwal, O. Consortium, and V. Scaria, “Computational analysis and predictive modeling of small molecule modulators of microRNA,” Journal of Cheminformatics, vol. 4, no. 8, article 16, 2012. View at Google Scholar · View at Scopus
  20. A. Simeonov, A. Jadhav, A. A. Sayed et al., “Quantitative high-throughput screen identifies inhibitors of the Schistosoma mansoni redox cascade,” PLoS Neglected Tropical Diseases, vol. 2, no. 1, article e127, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. W. A. Lea, A. Jadhav, G. Rai et al., “A 1,536-well-based kinetic HTS assay for inhibitors of Schistosoma mansoni thioredoxin glutathione reductase,” Assay and Drug Development Technologies, vol. 6, no. 4, pp. 551–555, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. Y. Wang, J. Xiao, T. O. Suzek, J. Zhang, J. Wang, and S. H. Bryant, “PubChem: a public information system for analyzing bioactivities of small molecules,” Nucleic Acids Research, vol. 37, no. 2, pp. W623–W633, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. K. Liu, J. Feng, and S. S. Young, “PowerMV: a software environment for molecular viewing, descriptor generation, data analysis and hit evaluation,” Journal of Chemical Information and Modeling, vol. 45, no. 2, pp. 515–522, 2005. View at Publisher · View at Google Scholar · View at Scopus
  24. M. Sud, MayaChemTools, 2010, http://www.mayachemtools.org/.
  25. R. R. Bouckaert, E. Frank, M. A. Hall et al., “WEKA: experiences with a java open-source project,” Journal of Machine Learning Research, vol. 11, pp. 2533–2541, 2010. View at Google Scholar · View at Scopus
  26. N. Friedman, D. Geiger, and M. Goldszmidt, “Bayesian network classifiers,” Machine Learning, vol. 29, no. 2-3, pp. 131–163, 1997. View at Publisher · View at Google Scholar · View at Scopus
  27. L. Breiman, “Random forests,” Machine Learning, vol. 45, no. 1, pp. 5–32, 2001. View at Publisher · View at Google Scholar · View at Zentralblatt MATH · View at Scopus
  28. J. L. Melville, E. K. Burke, and J. D. Hirst, “Machine learning in virtual screening,” Combinatorial Chemistry and High Throughput Screening, vol. 12, no. 4, pp. 332–343, 2009. View at Publisher · View at Google Scholar · View at Scopus
  29. R. Blagus and L. Lusa, “Class prediction for high-dimensional class-imbalanced data,” BMC Bioinformatics, vol. 11, article 523, 2010. View at Publisher · View at Google Scholar · View at Scopus
  30. C. Elkan, “The foundations of cost-sensitive learning,” in Proceedings of the 17th International Joint Conference on Artificial Intelligence (IJCAI '01), pp. 973–978, August 2001. View at Scopus
  31. Chemaxon: Budapest H, Library MCS, version 0.7, 2008.
  32. Chemaxon, Budapest, Hungary, Jcsearch version 5.8.2.
  33. E. F. Pettersen, T. D. Goddard, C. C. Huang et al., “UCSF Chimera—a visualization system for exploratory research and analysis,” Journal of Computational Chemistry, vol. 25, no. 13, pp. 1605–1612, 2004. View at Publisher · View at Google Scholar · View at Scopus
  34. P. T. Lang, D. Moustakas, S. Brozell et al., DOCK, Version 6.2, University of California, San Francisco, Calif, USA, 2008.
  35. E. C. Meng, B. K. Shoichet, and I. D. Kuntz, “Automated docking with grid-based energy evaluation,” Journal of Computational Chemistry, vol. 13, no. 4, pp. 505–524, 2004. View at Google Scholar
  36. N. M. O'Boyle, M. Banck, C. A. James, C. Morley, T. Vandermeersch, and G. R. Hutchison, “Open babel: an open chemical toolbox,” Journal of Cheminformatics, vol. 3, no. 10, article 33, 2011. View at Publisher · View at Google Scholar · View at Scopus
  37. J. J. Irwin and B. K. Shoichet, “ZINC—a free database of commercially available compounds for virtual screening,” Journal of Chemical Information and Modeling, vol. 45, no. 1, pp. 177–182, 2005. View at Publisher · View at Google Scholar · View at Scopus